Pharmacokinetic (PK) - pharmacodynamic (PD) study of gemcitabine (G) in a randomised phase II trial of carboplatin (C) combined with G at standard rate infusion or fixed dose rate infusion in patients with advanced non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Soo, RA
Lim, HL
Wang, LZ
Tham, LS
Soong, R
Lee, HS
Liang, S
Lee, SC
Boyer, M
Goh, BC
机构：
[1] Natl Univ Singapore Hosp, Singapore 117548, Singapore
[2] Natl Univ Singapore, Singapore 117548, Singapore
[3] Clin Trials & Epidemiol Res Unit, Singapore, Singapore
[4] Sydney Canc Ctr, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [31] Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer
    Sakakibara, T.
    Inoue, A.
    Sugawara, S.
    Maemondo, M.
    Ishida, T.
    Usui, K.
    Abe, T.
    Kanbe, M.
    Watanabe, H.
    Saijo, Y.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 795 - 799
  • [32] Phase I trial of dexamethasone (Dex), carboplatin (C) and gemcitabine (G) in untreated non-small cell lung cancer (NSCLC)
    Rinehart, J
    Robert, F
    Davidson, S
    DeShazo, M
    Buzby, L
    Clould, G
    LUNG CANCER, 2005, 49 : S266 - S267
  • [33] Phase I trial of dexamethasone (Dex), carboplatin (C) and gemcitabine (G) in untreated non-small cell lung cancer (NSCLC).
    Rinehart, JJ
    Davidson, S
    Deshazo, M
    Cloud, G
    Busby, L
    Robert, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
  • [34] Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC):: An AASLC phase II trial
    Krajnik, G
    Mohn-Staudner, A
    Thaler, J
    Greil, R
    Schmeikal, S
    Marhold, F
    Deutsch, J
    Preiss, P
    Malayeri, R
    Schäfer-Prokop, C
    Wein, W
    Huber, H
    Pirker, R
    ANNALS OF ONCOLOGY, 2000, 11 (08) : 993 - 998
  • [35] Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer
    Xiong, Jian Ping
    Feng, Miao
    Qiu, Feng
    Xu, Jun
    Tao, Qing Song
    Zhang, Ling
    Xiang, Xiao Jun
    Zhong, Lu Xing
    Yu, Feng
    Ma, Xu Tian
    Gong, Wang Yong
    LUNG CANCER, 2008, 60 (02) : 208 - 214
  • [36] Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer (NSCLC) treated with carboplatin/gemcitabine combination: a randomized phase II study
    Bar-Sela, G.
    Wollner, M.
    Agbarya, A.
    Zwergel, L.
    Maykler, I.
    Sharvit, L.
    Kuten, A.
    Haim, N.
    EJC SUPPLEMENTS, 2009, 7 (02): : 188 - 189
  • [37] Phase II study of gemcitabine (G) in combination with docetaxel (D) in advanced non-small-cell lung cancer (NSCLC) patients.: (Oncopaz and Hospitals Associated).
    García, C
    Milla, A
    Feliu, J
    Lorenzo, A
    Madroñal, C
    Gili, F
    Baena, JM
    ANNALS OF ONCOLOGY, 2000, 11 : 113 - 113
  • [38] Paclitaxel, carboplatin, and G-CSF in advanced non-small-cell lung cancer:: A phase I/II study
    Hübel, K
    Engert, A
    Schmitz, S
    Re, D
    Wassermann, K
    Ko, Y
    Schwandt, C
    Vetter, H
    Diehl, V
    Tesch, H
    ONKOLOGIE, 1998, 21 (04): : 310 - 314
  • [39] Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Karvounis, N
    Batzios, S
    Athanassiou, A
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3816 - 3821
  • [40] WEEKLY DOCETAXEL (TXT) WITH WEEKLY GEMCITABINE AS PROLONGED INFUSION (GEM) IN PATIENTS WITH ADVANCED, PRETREATED NON-SMALL-CELL LUNG CANCER (NSCLC): PRELIMINARY REPORT OF A PHASE II STUDY
    Antonelli, Giovanna
    Priolo, Domenico
    Amadio, Placido
    Colina, Paolo
    Vitale, Felice
    Ferrau, Francesco
    ANNALS OF ONCOLOGY, 2004, 15 : 31 - 31
12345